🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Ohio › Columbus

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Columbus, OH

10 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ap rekriteFaz 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • The James at Brain and Spine Hospital (OSU), Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Ap rekriteFaz 3
  • Central Ohio Urology Group, Gahanna · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • The Ohio State University (OSU), Columbus
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • Central Ohio Urology Group, Gahanna · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Ap rekriteEtid obsèvasyon
  • The Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07225127

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Ap rekriteFaz 1/2
  • The Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Ap rekriteFaz 4
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT07474519

Blue Light Cystoscopy With Cysview® Registry

Ap rekriteEtid obsèvasyon
  • Ohio State University Wexner Medical Center, Columbus
  • Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Ap rekriteFaz 2
  • Site 02-017 - Central Ohio Urology Group, Gahanna · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 24, 2025 · NCT03945162

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.